The CoronaVac COVID-19 vaccine has an excellent safety profile, but generates only a moderate immune response in people with…
Articles by Steve Bryson, PhD
Intensive care stays are more likely if oxygen-carrying hemoglobin levels are low at hospital admission in adults with kidney disease…
In the year before being diagnosed with ANCA-associated vasculitis (AAV), Medicare beneficiaries had significantly higher use and costs of…
Amgen is the new owner of Tavneos (avacopan), an approved ANCA-associated vasculitis (AAV) therapy, following its successful $3.7…
Immune macrophages or cells that carry the proteins CD163 and/or CD206 play a key role in kidney inflammation in people…
Tavneos (avacopan) has been approved as an add-on therapy for adults in Switzerland with severe, active microscopic polyangiitis (MPA)…
People with ANCA vasculitis (AAV) in long-term remission have increased arterial stiffness, a sign of cardiovascular disease, a study…
Elevated levels of certain pro-inflammatory proteins were found in the bloodstream and urine of people with ANCA-associated vasculitis (AAV),…
Symptoms affecting the eyes and ears are significantly more common in adults with ANCA-associated vasculitis (AAV) who developed hypertrophic…
Tavneos (avacopan) will soon be available as an add-on treatment for adults in England, Wales, and Northern Ireland with…